{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:28:54Z","timestamp":1761647334042},"reference-count":14,"publisher":"American Psychiatric Association Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2005,4,1]]},"DOI":"10.1176\/appi.ajp.162.4.645","type":"journal-article","created":{"date-parts":[[2005,3,30]],"date-time":"2005-03-30T20:17:53Z","timestamp":1112213873000},"page":"645-647","source":"Crossref","is-referenced-by-count":5,"title":["Searching for Methods to Detect, Prevent, and Treat Alzheimer\u2019s Disease"],"prefix":"10.1176","volume":"162","author":[{"given":"Jeffrey L.","family":"Cummings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"230","reference":[{"key":"R1624CHDBIGBF","doi-asserted-by":"crossref","unstructured":"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56:303\u2013308","DOI":"10.1001\/archneur.56.3.303"},{"key":"R1624CHDFCBJH","doi-asserted-by":"crossref","unstructured":"Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B: Current concepts in mild cognitive impairment. Arch Neurol 2001; 58:1985\u20131992","DOI":"10.1001\/archneur.58.12.1985"},{"key":"R1624CHDBDACE","doi-asserted-by":"crossref","unstructured":"Ritchie K, Touchon J: Mild cognitive impairment: conceptual basis and current nosological status. Lancet 2000; 355:225\u2013228","DOI":"10.1016\/S0140-6736(99)06155-3"},{"key":"R1624CHDDHFDG","doi-asserted-by":"crossref","unstructured":"Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN III, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J (WHIMS Investigators): Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women\u2019s Health Initiative Memory Study: a randomized controlled trial. JAMA 2003; 289:2651\u20132662","DOI":"10.1001\/jama.289.20.2651"},{"key":"R1624CHDJIHGE","doi-asserted-by":"crossref","unstructured":"Nilsen J, Mor G, Naftolin F: Raloxifene induces neurite outgrowth in estrogen receptor positive PC12 cells. Menopause 1998; 5:211\u2013216","DOI":"10.1097\/00042192-199805040-00005"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Wu X, Glinn MA, Ostrowski NL, Su Y, Ni B, Cole HW, Bryant HU, Paul SM: Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyltransferase activity in ovariectomized rats. Brain Res 1999; 847:98\u2013104","DOI":"10.1016\/S0006-8993(99)02062-4"},{"key":"R1624CHDCFGBD","doi-asserted-by":"crossref","unstructured":"Cyr M, Landry M, Di Paolo T: Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain. Neuropsychopharmacology 2000; 23:69\u201378","DOI":"10.1016\/S0893-133X(00)00085-3"},{"key":"R1624CHDBCFJE","doi-asserted-by":"crossref","unstructured":"Barrett-Connor E, Grady D, Sashegyi A, Anderson PW, Cox DA, Hoszowski K, Rautaharju P, Harper KD (MORE Investigators): Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA 2002; 287:847\u2013857","DOI":"10.1001\/jama.287.7.847"},{"key":"R1624CHDHEFEF","doi-asserted-by":"crossref","unstructured":"Jack CR Jr, Slomkowski M, Gracon S, Hoover TM, Felmlee JP, Stewart K, Xu Y, Shiung M, O\u2019Brien PC, Cha R, Knopman D, Petersen RC: MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology 2003; 60:253\u2013260","DOI":"10.1212\/01.WNL.0000042480.86872.03"},{"key":"R1624CHDIDDCD","doi-asserted-by":"crossref","unstructured":"Wolf BA, Wertkin AM, Jolly YC, Yasuda RP, Wolfe BB, Konrad RJ, Manning D, Ravi S, Williamson JR, Lee VM: Muscarinic regulation of Alzheimer\u2019s disease amyloid precursor protein secretion and amyloid beta-protein production in human neuronal NT2N cells. J Biol Chem 1995; 270:4916\u20134922","DOI":"10.1074\/jbc.270.9.4916"},{"key":"R1624CHDEDGGE","doi-asserted-by":"crossref","unstructured":"Svensson AL, Nordberg A: Tacrine and donepezil attenuate the neurotoxic effect of A beta(25\u201335) in rat PC12 cells. Neuroreport 1998; 9:1519\u20131522","DOI":"10.1097\/00001756-199805110-00050"},{"key":"R1624CHDFADHC","doi-asserted-by":"crossref","unstructured":"Davis KL, Thal LJ, Gamzu ER: A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer\u2019s disease. N Engl J Med 1992; 327:1253\u20131259","DOI":"10.1056\/NEJM199210293271801"},{"key":"R1624CHDIFCEE","doi-asserted-by":"crossref","unstructured":"Tariot PN, Solomon PR, Morris JC, Kershaw P, Lilienfeld S, Ding C (Galantamine USA-10 Study Group): A 5-month, randomized, placebo-controlled trial of galantamine in AD. Neurology 2000; 54:2269\u20132276","DOI":"10.1212\/WNL.54.12.2269"},{"key":"R1624CHDCCEAB","doi-asserted-by":"crossref","unstructured":"Krishnan KRR, Charles HC, Doraiswamy PM, Mintzer J, Weisler R, Yu X, Perdomo C, Ieni JR, Rogers S: Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer\u2019s disease. Am J Psychiatry 2003; 160:2003\u20132011","DOI":"10.1176\/appi.ajp.160.11.2003"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.162.4.645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T20:40:51Z","timestamp":1722285651000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.162.4.645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,1]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4,1]]}},"alternative-id":["10.1176\/appi.ajp.162.4.645"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.162.4.645","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"type":"print","value":"0002-953X"},{"type":"electronic","value":"1535-7228"}],"subject":[],"published":{"date-parts":[[2005,4,1]]}}}